Boston Biomedical Consultants (BBC) is a leading consulting services provider specializing in the In Vitro Diagnostics (IVD) industry for almost 40 years. Renowned for its expertise in market assessment, business strategy, emerging molecular testing, and cellular biology, BBC offers unparalleled primary market research capabilities and global-level consulting services. The company delivers customized, timely research reports and consulting services to its clients worldwide. Founded in 1977, BBC was acquired by IQVIA in August 2015.
There is no investment information
No recent news or press coverage available for Boston Biomedical Consultants.
We care about your data, and we'd love to use cookies make your experience better.
